VirnetX Announces Partnership with Solution Synergy
Security Provider Will Sell VirnetX Products to End Users to Protect Healthcare Providers and Cities from Cyber and Ransomware Attacks
"This will be a great partnership to advance our
"The cyber-attacks on healthcare and cities happening today are unprecedented," said
VirnetX One™ is a security-as-a-service platform that protects enterprise applications, services, and infrastructure from cyber-attacks using Zero Trust Network Access ("ZTNA"). VirnetX One™ products address a significant need across enterprises of all sizes, as hackers have become more sophisticated, ransomware and malware more costly and disruptive, and the use of corporate and other applications by contemporary remote workforces has continued to rise.
VirnetX Matrix™ provides superior security for internet-enabled enterprise applications and their connected devices, and for control systems currently deployed by those enterprises (e.g., file servers, data back-up systems, VPN/firewalls). VirnetX Matrix™ provides ZTNA protection, "single-click" ease of use, and is designed to be a highly effective "security umbrella": its added layer of protection is deployed simply, without the need for changes to an enterprise's existing, in-place infrastructure.
War Room™ provides an industry leading, safe, and secure video conferencing meeting environment where sensitive communications and data is invisible to those unauthorized to view it.
VirnetX Holding Corporation is an Internet security software and technology company with industry-leading, patented technology for Zero Trust Network Access ("ZTNA") based secure network communications. VirnetX's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One™, VirnetX War Room™, VirnetX Matrix™, and Gabriel Connection Technology™, are designed to be device- and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services, and critical infrastructures. The Company's patent portfolio includes over 200 U.S. and foreign granted patents, validations and pending applications. For more information, please visit www.virnetx.com.
SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS
This press release should be read in conjunction with our Annual Report on Form 10-K (the "Form 10-K"), which is expected to be filed with the
These forward-looking statements are based upon our current expectations, estimates, assumptions and beliefs concerning future events and conditions, and may discuss, among other things, expectations about products and product performance, expectations about future cash distributions or dividends and the impact of potential and ongoing litigation. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "will be," "will continue," "will likely result in" and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are necessarily subject to risks, uncertainties, and other factors, many of which are outside our control, and could cause actual results to differ materially from such statements and from our historical results and experience. These risks, uncertainties and other factors include, but are not limited to risks detailed in our filings with the
For example, this press release refers to:
- The ability of
VirnetXproducts to protect healthcare providers and cities from cyber and ransomware attacks.
- The effectiveness of the partnership with
Solution Synergyto the business and marketing of VirnetXproducts.
EXCEPT AS REQUIRED BY LAW, WE UNDERTAKE NO OBLIGATION TO UPDATE OR REVISE ANY FORWARD- LOOKING STATEMENT AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE.
VirnetX Holding Corporation